Joel Lillqvist´s research

Inequity in cardiovascular health – is prescription part of the problem?

Background: In the last decades the rate of cardiovascular disease (CVD) has declined, resulting in   prolonged lifespans. One contributing factor is the prescription of medicinces that prevent CVD to high-risk individuals. Individuals with a long education live five years longer than those with a short education. This is mainly due to a higher mortality in CVD and cancer for individuals with low education. Socioeconomic inequities in access to medicinces can contribute to inequity in health. Few studies investigate if there exists a socioeconomic gradient in the desire for medicines that prevent CVD.

Our first aim is to investigate if there exist an inequitable prescription of medicinces that prevent CVD. Our second aim is to further our understanding of why inequitable precription exists.

Method:

Study one: We will compare physicians that have no history of CVD or diabetes with controls of similarly long education and compare prescription of antihypertensives and statines.

Study two: We will study a random sample with no history of CVD or diabetes and compare prescription of antihypertensives and statines based on level of education and income.

Study three: A random sample will be asked to fill the Beliefs about Medicines questionnarie. We will investigate if there exists a social gradient in the attitudes towards medicines.

Study four: We will interview respondents from study 3 who are sceptical to medicines in order to explore their cognitive reasoning and views on how medicinces could be made more acceptable.

Joel´s e-mail: joel.lillqvist@umu.se